Tesmec - Investor Relations
OVERVIEW
INVESTOR.TESMEC.COM RANKINGS
Date Range
Date Range
Date Range
LINKS TO BUSINESS
WHAT DOES INVESTOR.TESMEC.COM LOOK LIKE?
INVESTOR.TESMEC.COM HOST
FAVORITE ICON
SERVER OPERATING SYSTEM AND ENCODING
I revealed that this domain is weilding the Microsoft-IIS/6.0 server.TITLE
Tesmec - Investor RelationsDESCRIPTION
Relazione Finanziaria Annuale 2017. Resoconto Intermedio di Gestione al 30 settembre 2017. Relazione Finanziaria Semestrale Consolidata al 30 giugno 2017. Nuovo contratto in Qatar relativo ad attività di gestione di una flotta di trencher. Il CdA approva il progetto di Bilancio al 31.12.2017 e il Bilancio Consolidato 31.12.2017. Calendario eventi societari 2018. 6 Aprile 2018 - Assemblea soci Approvazione del bilancio desercizio al 31 dicembre 2017. Presentazione STAR Conference 2017 - Londra.CONTENT
This web site investor.tesmec.com states the following, "Resoconto Intermedio di Gestione al 30 settembre 2017." Our analyzers noticed that the webpage said " Relazione Finanziaria Semestrale Consolidata al 30 giugno 2017." The Website also said " Nuovo contratto in Qatar relativo ad attività di gestione di una flotta di trencher. Il CdA approva il progetto di Bilancio al 31. 2017 e il Bilancio Consolidato 31. 6 Aprile 2018 - Assemblea soci Approvazione del bilancio desercizio al 31 dicembre 2017. Presentazione STAR Conference 2017 - Londra."SIMILAR WEB SITES
Announces Fourth Quarter 2017 Results. to Announce Fourth Quarter Earnings on February 20, 2018. 2016 Annual Report and 2017 Proxy Statement. VP, Finance and Investor Relations. 2018 Texas Roadhouse, Inc.
Textainer Group Holdings Limited Reports Second-Quarter Results and Declares Quarterly Dividend. Textainer Announces Date for the Second Quarter 2015 Earnings Release and Conference Call. Textainer Group Holdings Limited Reports First-Quarter Results and Declares Quarterly Dividend.
Annual Report and Proxy Materials. Annual Report and Proxy Materials. Investing for future growth, organically and through acquisitions, is a key focus for Textron. Annual Report and Proxy Materials.
Medicines That Make a Difference. Theravance Biopharma is a diversified biopharmaceutical company with the core purpose of creating medicines that make a difference in the lives of patients suffering from serious illness. Theravance Biopharma to Present at the 17th Annual Needham Healthcare Conference. Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update.
Greenway Strategy and Separate Account. Greenway Strategy and Separate Account. American Stock Transfer and Trust Company. 2015 THL Credit, Inc.